CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CTRVP

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/16	06 : 17	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/07/11	22 : 46	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/03/08	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/03/07	06 : 30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/22	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/22	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/21	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/08	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/12/07	22 : 41	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/11/28	20 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/11/21	05 : 59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/11/01	05 : 15	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/10/04	06 : 22	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/10/03	05 : 52	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/09/21	00 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/09/19	22 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/08/15	05 : 12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/07/15	06 : 12	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/05/13	05 : 19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/04/11	05 : 52	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/04/03	19 : 02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/22	07 : 08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/15	06 : 38	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/10	07 : 21	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/09	20 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/10/18	06 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/08/06	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/07/27	05 : 06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/07/25	20 : 13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/07/05	21 : 34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)